Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on Trastuzumab by Tatiana Strava Corrêa, Gustavo Duarte Ramos Matos, Marcos Segura, Carlos Henrique dos Anjos

Get full text

Metastatic Lobular Breast Cancer Mimicking Colitis by Renata Reis Figueiredo, Tatiana Strava Correa, Carlos Henrique dos Anjos, Heinrich Bender Kohnert Seidler

Get full text

Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications by Carlos Wagner S. Wanderley, Carlos Wagner S. Wanderley, Tatiana Strava Correa, Mariana Scaranti, Fernando Queiroz Cunha, Fernando Queiroz Cunha, Romualdo Barroso-Sousa

Get full text

Primary Peritoneal Carcinosarcoma in a Breast Cancer Patient Harboring a Germline BRCA2 Pathogenic Variant: Case Report by Luciana Beatriz Mendes Gomes, Renata Lazari Sandoval, Camila Bragança Xavier, Tatiana Strava Correa, Raquel Midori Koga Matuda, Zenaide Silva de Souza, Luiz Guilherme Cernaglia Aureliano de Lima, Mariana Petaccia de Macedo, Filomena Marino Carvalho, Daniele Assad Suzuki

Get full text

The addition of PD-1/PD-L1 axis blockade to BRAF and MEK inhibition for advanced melanoma patients harboring BRAF mutations: a systematic review and meta-analysis by Mauricio Fernando Silva Almeida Ribeiro, Camila Bragança Xavier, Allan Andresson Lima Pereira, Mariana Scaranti, Luiza Dib Batista Bugiato Faria, Tatiana Strava Correa, Marina Sahade, David Queiroz Borges Muniz, Olavo Feher, Gustavo dos Santos Fernandes, Artur Katz, Rodrigo Ramella Munhoz

Get full text

What can we learn from more than 1,000 Brazilian patients at risk of hereditary cancer? by Ana Carolina Rathsam Leite, Daniele Assad Suzuki, Allan Anderson Lima Pereira, Natalia Polidorio Machado, Romualdo Barroso-Sousa, Tatiana Strava Correa, Fernanda Cesar Moura, Igor Alexandre Protzner Morbeck, Brenda Pires Gumz, Luiza Dib Batista Bugiato Faria, Gustavo dos Santos Fernandes, Renata Lazari Sandoval

Get full text

Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil by Marcello Moro Queiroz, Karina Perez Sacardo, Mauricio Fernando Ribeiro, Luiza Lara Gadotti, Rodrigo Saddi, Leandro Jonata de Carvalho Oliveira, Rudinei Diogo Marques Linck, Marcelo Rocha de Souza Cruz, Romualdo Barroso-Sousa, Marina Sahade, Tatiana Strava Correa, Max Senna Mano, Daniele Assad Suzuki, Andrea Kazumi Shimada, Artur Katz

Get full text

Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study by Leandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Daniele Xavier Assad, Daniel Fontes Argolo, Solange Moraes Sanches, Laura Testa, José Bines, Rafael Kaliks, Maira Caleffi, Debora de Melo Gagliato, Marina Sahade, Romualdo Barroso-Sousa, Tatiana Strava Corrêa, Andrea Kazumi Shimada, Daniel Negrini Batista, Daniel Musse Gomes, Marcelle Goldner Cesca, Débora Gaudêncio, Larissa Matos Almeida Moura, Julio Antonio Pereira de Araújo, Artur Katz, Max Senna Mano

Get full text